---
title: Targeted Therapies
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Targeted Therapies #ğŸš§ æ–½å·¥ä¸­

### Targeted Therapies

â€¢Â Â Â Nomenclature:

-Â Â Â Small molecule inhibitors end in â€œ-inibâ€

-Â Â Â Monoclonal antibodies end in â€œ-mabâ€

â€¢Â Â Â Tyrosine kinase inhibitors: Small molecule inhibitors, given orally

-Â Â Â Imatinib (Gleevec), dasatinib: Bind to the inactive form of BCR-ABL and prevent activation. Used for treatment of CML.

-Â Â Â Osimertinib, erlotinib: EGFR inhibitors used in NSCLC

-Â Â Â Sorafenib, sunitinib: VEGF inhibitors used in HCC, RCC, thyroid

â€¢Â Â Â Monoclonal antibodies: Given via infusion

-Â Â Â Anti-HER2: Trastuzumab (Herceptin), pertuzumab (Perjeta) used in breast cancer. Trastuzumab also used in esophageal/gastric cancer.

-Â Â Â Anti-CD20: Rituximab, targets B-cells, used in B-cell lymphomas

-Â Â Â Anti-VEGF: Bevacizumab (Avastin), inhibits angiogenesis, used in colon cancer, RCC

